V-CARD
PHONE
+1 202 637 5818
FAX
+1 202 637 5910
|
|
Isabel
P.
Dunst
Partner, Washington, D.C.
isabel.dunst@hoganlovells.com
Isabel Dunst’s practice focuses on a broad array of health care issues, with an emphasis on coverage, reimbursement, and payment issues often involving new technologies. She also counsels extensively on issues relating to state and federal regulation of health care providers, including both regulatory counseling and representation in investigations resulting from the highly regulated nature of the health care industry, such as federal and state fraud and abuse rules. Isabel's clients represent a diverse cross-section of the health care industry, including pharmaceutical and medical device companies, direct health care providers, health care reimbursers, and health care trade associations.
Before joining Hogan & Hartson in 1990, Isabel completed her career at the U.S. Department of Health & Human Services (HHS) where she had held a number of positions in the general counsel’s office, as the deputy general counsel of the department, the senior career legal position. As deputy general counsel, Isabel provided and coordinated legal advice to all components of HHS, including the Office of the Secretary, the Health Care Financing Administration, the Public Health Service, the Food and Drug Administration, the Office of the Inspector General, and the Social Security Administration, both in Washington, D.C. and in the 10 regional offices of the department.
Hogan Lovells Publications
24 February 2012
"CMS releases proposed rule on reporting and returning overpayments from the Medicare program." Health Alert, Hogan Lovells
10 February 2012
"Proposed rule for federal Sunshine Act requires public disclosure of research payments." Health Alert, Hogan Lovells
16 December 2011
"CMS proposes rule to implement Federal Physician Payment Sunshine Act." Health Alert, Hogan Lovells
18 August 2011
"Recalculating personal exclusion risk." Health Alert, Hogan Lovells
21 December 2010
"Sobering developments on federal healthcare program exclusion." Health Alert, Hogan Lovells
21 September 2010
"CMS and FDA Announce New Parallel Review Process for Medical Products." Health Alert, Hogan Lovells
June 2010
"False Claims Act Settlement Calls into Question Some Medical Product Rebate Practices." Health Alert, Hogan Lovells
|
|
|